Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations

Journal of Thoracic and Cardiovascular Surgery

Volumn 114, Issue 1, 1997, Pages 117-122

  Velthuis, H T ^a   Baufreton, C ^a   Jansen, P G M ^a   Thijs, C M ^a   Hack, C E ^a   Sturk, A ^a   Wildevuur, C R H ^a   Loisance, D Y ^a  

^a CLTNRCBTS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 12A; COMPLEMENT COMPONENT C1S INHIBITOR; HEPARIN; KALLIKREIN; PLASMIN; PREKALLIKREIN; PROTHROMBIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; FEMALE; FIBRINOLYSIS; HEPARINIZATION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030746047     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(97)70124-7     Document Type: Article

References (30)

1. PGM Jansen H te Velthuis RAJM Huybreghts Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits J Thorac Cardiovasc Surg 110 1995 829 834
2. H Te Velthuis PGM Jansen CE Hack L Eijsman CRH Wildevuur Specific complement inhibition with heparin-coated extracorporeal circuits Ann Thorac Surg 61 1996 1153 1157
3. V Videm JL Svennevig E Fosse G Semb A Østerud TE Mollnes Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations J Thorac Cardiovasc Surg 103 1992 806 813
4. AP Kaplan M Silverberg The coagulation-kinin pathway of human plasma Blood 70 1987 1 15
5. RW Colman Surface-mediated defense reactions: the plasma contact activation system J Clin Invest 73 1984 1249 1253
6. B Ghebrehiwet M Silverberg AP Kaplan Activation of classical pathway of complement by Hageman factor fragment J Exp Med 153 1981 665 676
7. WA Wuillemin M Minnema JCM Meijers Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor Blood 85 1995 1517 1526
8. JH Nuijens CCM Huijbreghts AJM Eerenberg-Belmer Quantitation of plasma factor XIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes in sepsis Blood 72 1988 1841 1848
9. JH Nuijens CCM Huijbreghts B Cohen Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of Hageman factor-C1-inhibitor and kallikrein-C1-inhibitor complexes by specific radioimmunoassays Thromb Haemost 58 1987 778 784
10. 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay Thromb Haemost 67 1992 111 116
11. 2-plasmin-inhibitor complexes during cardiopulmonary bypass Blood 73 1989 468 471
12. UE Kongsgaard N Smith-Erichsen O Geiran E Amundsen TE Mollnes P Garred Different activation patterns in the plasma kallikrein-kinin and complement systems during coronary bypass surgery Acta Anaesthesiol Scand 33 1989 343 347
13. AAEA De Smet JM ChangNjoek W van Oeveren Increased anticoagulation during cardiopulmonary bypass by aprotinin J Thorac Cardiovasc Surg 100 1990 520 527
14. YT Wachtfogel U Kucich CE Hack Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion J Thorac Cardiovasc Surg 106 1993 1 10
15. YT Wachtfogel CE Hack JH Nuijens Selective kallikrein inhibitors after human neutrophil elastase release during extracorporeal circulation Am J Physiol 268 1995 H1352 H1357
16. RR Rent R Myhrman BA Fiedel H Gewurz Potentiation of C1 esterase inhibitory activity by heparin Clin Exp Immunol 23 1976 264 271
17. RA Pixley A Schmaier RW Colman The effect of factor XII activating compounds on factor XIIa and factor XIIf inhibition by C1 inhibitor Fed Proc 45 1986 1638A
18. T Nilsson On the interaction between kallikrein and C1-esterase inhibitor Thromb Haemost 49 1983 193 195
19. ST Olson R Sheffer AM Francis High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein Biochemistry 32 1993 12136 12147
20. ST Olson AM Francis R Sheffer J Choay Parallel mechanism of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions Biochemistry 32 1993 12148 12159
21. J Sanchez G Elgue J Riesenfeld P Olsson Control of contact activation on endpoint immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence J Biomed Mater Res 29 1995 655 661
22. K Kodama B Pasche P Olsson Antithrombin III binding to surface immobilized heparin and its relation to FXa inhibitors Thromb Haemost 58 1987 1064 1067
23. B Pasche K Kodama O Larm P Olsson J Swedenborg Thrombin inactivation on surfaces with covalently bonded heparin Thromb Res 44 1986 739 748
24. WR Wagner PC Johnson KA Thompson GC Marrone Heparin coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss Ann Thorac Surg 58 1994 734 741
25. E Øvrum F Brosstad EÅ Holen G Tangen M Abdelnoor Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass Circulation 92 1995 2579 2584
26. RC Gorman NP Ziats A Koneti Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass J Thorac Cardiovasc Surg 111 1996 1 12
27. RM Moorman DS Reynolds ME Comunale Management of cardiopulmonary bypass in a patient with congenital factor XII deficiency J Cardiothorac Vasc Anesth 7 1993 452 454
28. JF Burman HI Chung DA Lane H Philippou A Adami JCR Lincoln Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass Lancet 344 1994 1192 1193
29. M Levi CE Hack JP de Boer DPM Brandjes HR Büller JW ten Cate Reduction of contact activation related fibrinolytic activity in factor XII deficient patients: further evidence for the role of the contact system in fibrinolysis in vivo J Clin Invest 88 1991 1155 1160
30. B Lammle WA Wuillemin I Huber Thromboembolism and bleeding tendency in congenital factor XII deficiency: a study on 74 subjects from 14 Swiss families Thromb Haemost 65 1991 117 121